Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

Go back to Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) Delayed: 31.39 +0.01 (0.03%)
Previous Close $31.38    52 Week High $3.00 
Open $31.39    52 Week Low $0.51 
Day High $31.40    P/E N/A 
Day Low $31.37    EPS $-0.25 
Volume 684,305